CAV1 and metastatic neoplasm: To further support the implication of Cav-1/ACC1/FASN signaling in the progression of PCa we performed Cav-1, ACC1 and FASN immunostaining in normal prostate tissues, primary untreated and ADT treated PCa and metastatic disease.